Trial · NCT07906626
Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life
NCT07906626, Not applicable, Completed, Universitas Sumatera Utara
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life. Trials, record NCT07906626. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906626
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Snakehead Fish Extract and Curcumin Co-Supplementation in Advanced Lung Cancer on Inflammation, Nutritional Status, and Quality of Life
- NCT number
- NCT07906626
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- Universitas Sumatera Utara
- Conditions
- Lung Cancer (NSCLC)
- Interventions
- Snakehead Fish Extract and Curcumin, Placebo
- First posted
- 2026-10-30
- Last updated
- 2026-11-12
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in body weight at 9 weeks | Baseline and After 9 weeks | Body weight is measured in kilograms (kg) using a calibrated digital health scale at baseline and after 9 weeks of intervention. The metric is calculated as the post-intervention value minus the baseline value. |
| Secondary | Change from baseline in serum C-reactive protein (CRP) levels at 9 weeks | Baseline and After 9 weeks | Serum CRP levels are measured from venous blood samples using enzyme-linked immunosorbent assay (ELISA) and expressed in milligrams per deciliter (mg/dL). |
| Secondary | Change from baseline in serum tumor necrosis factor-alpha (TNF-alpha) levels at 9 weeks | Baseline and After 9 weeks | Serum TNF-alpha levels are measured from venous blood samples using enzyme-linked immunosorbent assay (ELISA) and expressed in picograms per milliliter (pg/mL). |
| Secondary | Change from baseline in serum interleukin-6 (IL-6) levels at 9 weeks | Baseline and After 9 weeks | Serum IL-6 levels are measured from venous blood samples using enzyme-linked immunosorbent assay (ELISA) and expressed in picograms per milliliter (pg/mL). |
| Secondary | Change from baseline in mid-upper arm circumference (MUAC) at 9 weeks | Baseline and After 9 weeks | MUAC is measured in centimeters (cm) on the relaxed left arm at the midpoint between the acromion and olecranon process using a non-elastic measuring tape. |
| Secondary | Change from baseline in Body Mass Index (BMI) at 9 weeks | Baseline and After 9 weeks | BMI is calculated as body weight in kilograms divided by height in meters squared (kg/m²). |
| Secondary | Change from baseline in EORTC QLQ-C30 functional scale scores at 9 weeks | Baseline and After 9 weeks | Evaluates physical, role, emotional, cognitive, and social functioning using the EORTC QLQ-C30. Scores range from 0 to 100, where a higher score indicates a higher/better level of functioning. |
| Secondary | Change from baseline in EORTC QLQ-C30 symptom scale scores at 9 weeks | Baseline and After 9 weeks | Evaluates symptoms including fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties. Scores range from 0 to 100, where a higher score indicates a higher level of symptoms or greater symptom burden. |
| Secondary | Change from baseline in EORTC QLQ-C30 global health status score at 9 weeks | Baseline and After 9 weeks | Assessed using the Indonesian version of the EORTC QLQ-C30 questionnaire. Global health status scores range from 0 to 100, where a higher score represents a better overall quality of life and higher level of general health. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906626
GET https://conductscience.org/api/trials/v1/NCT07906626/registered